Back
Sarepta Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
SRPT
Sarepta Therapeutics
Last Price:
$21.99
Seasonality Move:
29.39%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.6 | Sell |
| 20-day SMA: | 18.6 | Sell |
| 50-day SMA: | 30.56 | Sell |
| 200-day SMA: | 87.14 | Sell |
| 8-day EMA: | 15.43 | Buy |
| 20-day EMA: | 9.43 | Buy |
| 50-day EMA: | 4.58 | Buy |
| 200-day EMA: | 1.27 | Buy |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.08 | Buy |
| Relative Strength Index (14 RSI): | 31.79 | Sell |
| Chaikin Money Flow: | 7064730 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.71 - 28.77) | Sell |
| Bollinger Bands (100): | (25.12 - 81.7) | Sell |
Sarepta Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 18.38 while SRPT 8-day simple moving average is 18.60, which is a Sell signal.
-
The stock price of SRPT is 18.38 while Sarepta Therapeutics 20-day SMA is 18.60, which makes it a Sell.
-
Sarepta Therapeutics 50-day simple moving average is 30.56 while SRPT share price is 18.38, making it a Sell technically.
-
SRPT stock price is 18.38 and Sarepta Therapeutics 200-day simple moving average is 87.14, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
46
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a SellThe current Sarepta Therapeutics [SRPT] share price is $18.38. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
1.8B
Price in USD:
18.38
Share Volume:
13M
Sarepta Therapeutics 52-Week Range
52-Week High:
150.48
52-Week Low:
16.88
Sell
46
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?The Sarepta Therapeutics stock price is 18.38 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 18.38 while SRPT 8-day exponential moving average is 15.43, which is a Buy signal.
-
The stock price of SRPT is 18.38 while Sarepta Therapeutics 20-day EMA is 9.43, which makes it a Buy.
-
Sarepta Therapeutics 50-day exponential moving average is 4.58 while SRPT share price is 18.38, making it a Buy technically.
-
SRPT stock price is 18.38 and Sarepta Therapeutics 200-day simple moving average is 1.27, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.77 per share, a decrease this year of $5.77 per share, and an increase next year of $5.30 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is 5.08, suggesting Sarepta Therapeutics is a Buy
-
Sarepta Therapeutics Relative Strength Index (RSI) is 31.79, which suggest Sarepta Therapeutics is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics is (14.71 - 28.77), which suggest Sarepta Therapeutics is a Sell
-
The Bollinger Bands (100) for Sarepta Therapeutics is (25.12 - 81.7), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.